#MCPro: This time, #AurobindoPharma makes the cut as the Tactical Pick. While the large-cap #stock is playing catch-up on the valuation front, the vaccine play offers a big canvas for growth.
https://www.moneycontrol.com/news/business/moneycontrol-research/weekly-tactical-pick-aurobindo-pharma-6543181.html?utm_source=telegram&utm_medium=social
https://www.moneycontrol.com/news/business/moneycontrol-research/weekly-tactical-pick-aurobindo-pharma-6543181.html?utm_source=telegram&utm_medium=social
Moneycontrol
Weekly Tactical Pick | Aurobindo Pharma
Valuation at a discount to peers, but significant scope for margin improvement
Aurobindo Pharma, which is in the race to develop and manufacture a #COVID19 vaccine, said there has been some delay in the #vaccine development at its partner's end. Read more:
https://www.moneycontrol.com/news/business/companies/aurobindo-pharma-faces-delay-in-getting-its-covid-19-vaccine-plan-rolling-7376311.html?utm_source=telegram&utm_medium=social
#CovidVaccines #AurobindoPharma
https://www.moneycontrol.com/news/business/companies/aurobindo-pharma-faces-delay-in-getting-its-covid-19-vaccine-plan-rolling-7376311.html?utm_source=telegram&utm_medium=social
#CovidVaccines #AurobindoPharma
Moneycontrol
Aurobindo Pharma Faces Delay In Getting Its COVID-19 Vaccine Plan Rolling
Aurobindo Pharma has exclusive rights to develop and commercialise UB-612 in India and to UNICEF, and non-exclusive rights in other select emerging markets. The company can supply up to 480 million doses of UB-612 for India and other countries.
#MCPropanorama: As the #economy stares at a long recovery, it’s rural India that is not playing ball – in contrast to its urban counterpart. The numbers on the ground tell the story. Also on, #AurobindoPharma, CCL, #Relaxo and more.
https://www.moneycontrol.com/news/business/markets/moneycontrol-pro-panorama-now-rural-india-falls-behind-the-curve-7381701.html?utm_source=telegram&utm_medium=social
https://www.moneycontrol.com/news/business/markets/moneycontrol-pro-panorama-now-rural-india-falls-behind-the-curve-7381701.html?utm_source=telegram&utm_medium=social
Moneycontrol
Moneycontrol Pro Panorama | Now, Rural India Falls Behind The Curve
In today’s edition of Moneycontrol Pro Panorama: Where economy is headed, rains fail to make a splash, how to play midcaps and smallcaps, enter asset sales, CCL stirs up a perfect brew, questions on ESG investing and more
#TradeSetup for August 3rd ⚡️#Lupin, #Voltas, #AurobindoPharma And More!
These are the #stocks that will possibly be in the spotlight during #trading hours tomorrow.
Watch the video to know why these #stocks are buzzing before the #OpeningBell! 🎥 https://www.youtube.com/watch?v=p2yVd5ACfkIhttps://bit.ly/3OMZXEc
These are the #stocks that will possibly be in the spotlight during #trading hours tomorrow.
Watch the video to know why these #stocks are buzzing before the #OpeningBell! 🎥 https://www.youtube.com/watch?v=p2yVd5ACfkIhttps://bit.ly/3OMZXEc
This media is not supported in your browser
VIEW IN TELEGRAM
Coming Up On #MorningTrade🔥
European stocks were mixed on Friday as the buoyance triggered by a softer-than-expected US consumer price index reading fizzled out. Meanwhile, S&P500 closed out its best week since June while Nasdaq added about 1.9% as investors snapped up tech shares on hopes that interest rates would ease.
#AurobindoPharma may come under pressure after Q2 profits drop over 40%. Remember the shares had seen a massive selloff last week on concerns over corporate governance.
#Stocks in the spotlight today – #LIC, #GlenmarkPharma and #ZeeEntertainment.
🔴Live @ 8.30 AM: https://www.youtube.com/watch?v=oS08T5Q_eUY
European stocks were mixed on Friday as the buoyance triggered by a softer-than-expected US consumer price index reading fizzled out. Meanwhile, S&P500 closed out its best week since June while Nasdaq added about 1.9% as investors snapped up tech shares on hopes that interest rates would ease.
#AurobindoPharma may come under pressure after Q2 profits drop over 40%. Remember the shares had seen a massive selloff last week on concerns over corporate governance.
#Stocks in the spotlight today – #LIC, #GlenmarkPharma and #ZeeEntertainment.
🔴Live @ 8.30 AM: https://www.youtube.com/watch?v=oS08T5Q_eUY
This media is not supported in your browser
VIEW IN TELEGRAM
On #MorningTrade 🔥
We analyse technicals and fundamentals of stocks like #AurobindoPharma, #CholaFinancial & Balrampur Chini
We also answer your stock queries LIVE SHRIKANT CHOUHAN, KOTAK SECURITIES and Bharat Gianani, MC Pro.
Live @ 8.30 AM https://www.youtube.com/watch?v=vP2aVPCRZYA
We analyse technicals and fundamentals of stocks like #AurobindoPharma, #CholaFinancial & Balrampur Chini
We also answer your stock queries LIVE SHRIKANT CHOUHAN, KOTAK SECURITIES and Bharat Gianani, MC Pro.
Live @ 8.30 AM https://www.youtube.com/watch?v=vP2aVPCRZYA
Coming Up On #MorningTrade 🔥
👉 Newly listed stocks catch MFs’ fancy, mop up Rs 850 cr in days; Should you buy too?
👉 How will the #market react to IndusInd Bank’s Q3 results?
👉 Will #HUL manage to meet analyst expectations?
👉 On the show today, we’ll address all these stocks & more!
⚡️ Tune in at 8.30 am!
https://www.youtube.com/watch?v=oGWh8mFoS9M
👉 Newly listed stocks catch MFs’ fancy, mop up Rs 850 cr in days; Should you buy too?
👉 How will the #market react to IndusInd Bank’s Q3 results?
👉 Will #HUL manage to meet analyst expectations?
👉 On the show today, we’ll address all these stocks & more!
⚡️ Tune in at 8.30 am!
https://www.youtube.com/watch?v=oGWh8mFoS9M
YouTube
Stock Market Live: Should You Buy Kfin, Sula, Elin & Other Newly Listed Cos? Adani Ent, HUL In Focus
Why newly listed stocks caught MFs’ fancy, should you buy too? We find out on the show.
Stocks in focus are HUL, Adani Enterprises, IndusInd Bank and Aurobindo Pharma.
#live #nifty #stockmarket #stockmarketlive #marketslive #sensex #kfintech #sula #elin…
Stocks in focus are HUL, Adani Enterprises, IndusInd Bank and Aurobindo Pharma.
#live #nifty #stockmarket #stockmarketlive #marketslive #sensex #kfintech #sula #elin…